On the Barrier Properties of the Cornea: A Microscopy Study of the Penetration of Fluorescently Labeled Nanoparticles, Polymers, and Sodium Fluorescein

Ellina A. Mun; Peter W. J. Morrison; Adrian C. Williams; Vitaliy V. Khutoryanskiy

doi:10.1021/mp500332m

journal article Aug 28, 2014

On the Barrier Properties of the Cornea: A Microscopy Study of the Penetration of Fluorescently Labeled Nanoparticles, Polymers, and Sodium Fluorescein

Ellina A. Mun Peter W. J. Morrison Adrian C. Williams Vitaliy V. Khutoryanskiy

Molecular Pharmaceutics Vol. 11 No. 10 pp. 3556-3564 · American Chemical Society (ACS)

View at Publisher Save 10.1021/mp500332m

Topics

No keywords indexed for this article. Browse by subject →

References

54

[1]

Yorio T. (2008)

[2]

World Health Organization [http://www.who.int/blindness/history/en/].

[3]

Hornof M. Eur. J. Pharm. Biopharm. (2005) 10.1016/j.ejpb.2005.01.009

[4]

Ranta V. P. Adv. Drug Delivery Rev. (2006) 10.1016/j.addr.2006.07.025

[5]

Laude A. Prog. Retinal Eye Res. (2010) 10.1016/j.preteyeres.2010.04.003

[6]

Wilson C. G. Exp. Eye Res. (2004) 10.1016/j.exer.2003.10.004

[7]

Hughes P. M. Adv. Drug Delivery Rev. (2005) 10.1016/j.addr.2005.09.004

[8]

Bochot A. J. Controlled Release (2012) 10.1016/j.jconrel.2012.01.019

[9]

Thrimawithana T. R. Drug Discovery Today (2011) 10.1016/j.drudis.2010.12.004

[10]

Geroski D. H. Invest. Ophthalmol. Visual Sci. (2000)

[11]

Urtti A. Adv. Drug Delivery Rev. (2006) 10.1016/j.addr.2006.07.027

[12]

Jarvinen K. Adv. Drug Delivery Rev. (1995) 10.1016/0169-409x(95)00010-5

[13]

Washington, N.; Washington, C.; Wilson, C. G.Physiological Pharmaceutics. Barriers to drug absorption,2nd ed.Taylor and Francis: 2001; pp249–270. 10.1201/9780203483701

[14]

Hillery, A. M.; Lloyd, A. W.; Swarbick, J.Drug delivery and targeting for pharmacists and pharmaceutical scientists;CRC Press: 2001; pp329–353.

[15]

Huang H. S. J. Pharm. Sci. (1983) 10.1002/jps.2600721109

[16]

Huang A. J. W. Invest. Ophthalmol. Visual Sci. (1989)

[17]

Sahoo S. K. Drug Discovery Today (2008) 10.1016/j.drudis.2007.10.021

[18]

Eljarrat-Binstock E. J. Controlled Release (2008) 10.1016/j.jconrel.2007.11.016

[19]

Baba K. J. Controlled Release (2011) 10.1016/j.jconrel.2011.04.019

[20]

Campos A. M. Int. J. Pharm. (2001) 10.1016/s0378-5173(01)00760-8

[21]

Qu X. Biomacromolecules (2006) 10.1021/bm0604000

[22]

Calvo P. Int. J. Pharm. (1997) 10.1016/s0378-5173(97)00083-5

[23]

Irmukhametova G. S. Langmuir (2011) 10.1021/la201385h

[24]

Irmukhametova G. S. Langmuir (2012) 10.1021/la2038735

[25]

Mun E. A. Langmuir (2014) 10.1021/la4029035

[26]

Suhonen P. Eur. J. Pharm. Sci. (1998) 10.1016/s0928-0987(97)10002-1

[27]

Tegtmeyer S. Eur. J. Pharm. Biopharm. (2001) 10.1016/s0939-6411(01)00123-0

[28]

Baydoun L. Eur. J. Pharm. Biopharm. (2003) 10.1016/s0939-6411(03)00036-5

[29]

Reichl S. Eur. J. Pharm. Biopharm. (2005) 10.1016/j.ejpb.2004.09.016

[30]

Friedrich I. Int. J. Pharm. (2005) 10.1016/j.ijpharm.2005.09.007

[31]

Morrison P. W. J. Mol. Pharmaceutics (2013) 10.1021/mp3005963

[32]

Qi H. P. Eur. J. Pharmacol. (2013) 10.1016/j.ejphar.2013.02.031

[33]

Jingjing L. Eur. J. Pharmacol. (2012) 10.1016/j.ejphar.2011.12.007

[34]

Diebold Y. Prog. Retinal Eye Res. (2010) 10.1016/j.preteyeres.2010.08.002

[35]

Loftsson T. Int. J. Pharm. (2001) 10.1016/s0378-5173(01)00761-x

[36]

Bary A. R. Eur. J. Pharm. Biopharm. (2000) 10.1016/s0939-6411(00)00108-9

[37]

Hao J. Exp. Eye Res. (2009) 10.1016/j.exer.2009.08.001

[38]

Kaur H. Int. J. Biol. Macromol. (2012) 10.1016/j.ijbiomac.2011.11.017

[39]

Sharma R. Carbohydr. Polym. (2012) 10.1016/j.carbpol.2011.09.065

[40]

Muchtar S. J. Controlled Release (1997) 10.1016/s0168-3659(96)01503-9

[41]

Amrite A. C. Mol. Vision (2008)

[42]

Advances in Mucoadhesion and Mucoadhesive Polymers

Vitaliy V. Khutoryanskiy

Macromolecular Bioscience 2011 10.1002/mabi.201000388

[43]

Prydal J. I. Eye (1993) 10.1038/eye.1993.96

[44]

Bernkop-Schnurch A. Adv. Drug Delivery Rev. (2005) 10.1016/j.addr.2005.07.002

[45]

Deutel B. Biomacromolecules (2008) 10.1021/bm700916h

[46]

Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus

Gregor Wollensak, Eberhard Spoerl, Theo Seiler

American Journal of Ophthalmology 2003 10.1016/s0002-9394(02)02220-1

[47]

Newsome D. A. Invest. Ophthalmol. Visual Sci. (1982)

[48]

Meek K. M. Micron (2001) 10.1016/s0968-4328(00)00041-x

[49]

Meek K. M. Exp. Eye Res. (2004) 10.1016/j.exer.2003.07.003

[50]

Saika S. Jpn. J. Ophthalmol. (1996)

Showing 50 of 54 references

Metrics

129

Citations

54

References

Details

Published: Aug 28, 2014
Vol/Issue: 11(10)
Pages: 3556-3564
License: View

Authors

E

Ellina A. Mun

Reading School of Pharmacy, University of Reading, Whiteknights, Reading, RG6 6AD, United Kingdom

P

Peter W. J. Morrison

Reading School of Pharmacy, University of Reading, Whiteknights, Reading, RG6 6AD, United Kingdom

A

Adrian C. Williams

Reading School of Pharmacy, University of Reading, Whiteknights, Reading, RG6 6AD, United Kingdom

V

Vitaliy V. Khutoryanskiy

Reading School of Pharmacy, University of Reading, Whiteknights, Reading, RG6 6AD, United Kingdom

Cite This Article

Ellina A. Mun, Peter W. J. Morrison, Adrian C. Williams, et al. (2014). On the Barrier Properties of the Cornea: A Microscopy Study of the Penetration of Fluorescently Labeled Nanoparticles, Polymers, and Sodium Fluorescein. Molecular Pharmaceutics, 11(10), 3556-3564. https://doi.org/10.1021/mp500332m

On the Barrier Properties of the Cornea: A Microscopy Study of the Penetration of Fluorescently Labeled Nanoparticles, Polymers, and Sodium Fluorescein

You May Also Like